Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer
Chemo-radiotherapy (CRT) remains the main treatment modality for non-small-cell lung cancer (NSCLC). However, its clinical efficacy is largely limited by individual variations in radio-sensitivity and radiotherapy-associated toxicity. There is an urgent need to identify genetic determinants that can...
Main Authors: | Kewen He, Shaotong Zhang, Jiaohui Pang, Jiani C. Yin, Dianbin Mu, Jun Wang, Hong Ge, Jie Ma, Zhe Yang, Xiaoli Zheng, Lihua Dong, Junli Zhang, Pengyu Chang, Li Li, Shanshan Tang, Hua Bao, Xue Wu, Xiaonan Wang, Yang Shao, Jinming Yu, Shuanghu Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.928605/full |
Similar Items
-
Genomic features, evolutionary patterns and minimal residual disease at surgical margins as novel prognostic/predictive biomarkers in locally advanced rectal cancer
by: Kewen He, et al.
Published: (2023-06-01) -
Bio-chemo-mechanics of the thoracic aorta
by: Sashini Iddawela, et al.
Published: (2021-02-01) -
Effects of Radiotherapy and Chemotherapy on Platelet in Patients with Lung Cancer
by: Shanshan Tang, et al.
Published: (2023-11-01) -
Fasting enhances the response of glioma to chemo- and radiotherapy.
by: Fernando Safdie, et al.
Published: (2012-01-01) -
Impact of thoracic radiotherapy on first‐line treatment outcomes in ES‐SCLC patients
by: Xiaoli Mu, et al.
Published: (2024-09-01)